3-{1-[6-(4-Benzyloxy-3,5-dimethyl-benzoyl)-pyrimidin-4-yl]-piperidin-4-yl}-7-methoxy-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one → 3-{1-[6-(4-Hydroxy-3,5-dimethyl-benzoyl)-pyrimidin-4-yl]-piperidin-4-yl}-7-methoxy-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one
Reaction equation
C([O:8][C:9]1[C:42]([CH3:43])=[CH:41][C:12]([C:13]([C:15]2[N:20]=[CH:19][N:18]=[C:17]([N:21]3[CH2:26][CH2:25][CH:24]([N:27]4[CH2:33][CH2:32][C:31]5[CH:34]=[C:35]([O:38][CH3:39])[CH:36]=[CH:37][C:30]=5[NH:29][C:28]4=[O:40])[CH2:23][CH2:22]3)[CH:16]=2)=[O:14])=[CH:11][C:10]=1[CH3:44])C1C=CC=CC=1.[H][H]>[Pd].CO>[OH:8][C:9]1[C:42]([CH3:43])=[CH:41][C:12]([C:13]([C:15]2[N:20]=[CH:19][N:18]=[C:17]([N:21]3[CH2:22][CH2:23][CH:24]([N:27]4[CH2:33][CH2:32][C:31]5[CH:34]=[C:35]([O:38][CH3:39])[CH:36]=[CH:37][C:30]=5[NH:29][C:28]4=[O:40])[CH2:25][CH2:26]3)[CH:16]=2)=[O:14])=[CH:11][C:10]=1[CH3:44]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
70 mg (0.10 mmol) 3-{1-[6-(4-benzyloxy-3,5-dimethyl-benzoyl)-pyrimidin-4-yl]-piperidin-4-yl}-7-methoxy-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one and 20 mg palladium on charcoal (Pd/C 10%) in 10 mL MeOH were hydrogenated for 30 min at RT in a hydrogen atmosphere of 10 psi. After filtration of the reaction mixture the solvent was eliminated i. vac. and the residue was purified by preparative HPLC-MS. The fractions containing the product were combined and freeze-dried.
Workup
- filtrationAfter filtration of the reaction mixture the solvent
- customand the residue was purified by preparative HPLC-MS
- additionThe fractions containing the product
- customfreeze-dried
Sources & evidence
- ORD record
- ord-10e91efbf6d64abda2b86c8b3b4c99c1
- Source dataset
- uspto-grants-2014_01
- Patent number
- US08629137B2
Reaction notes
Loading…